Autoimmune gastritis;La gastrite autoimmune

Rivista Italiana della Medicina di Laboratorio

Volumn 4, Issue 2, 2008, Pages 125-133

  Antico, A ^a,b  

^a Azienda ULSS   (Italy)

^b Laboratorio Analisi   (Italy)

Author keywords

Autoimmune gastritis; Parietal cell antibodies; Pernicious anaemia

Indexed keywords

ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; GASTRITIS; HYPERGASTRINEMIA; PERNICIOUS ANEMIA; REVIEW; STOMACH ACID SECRETION;

EID: 54049146720     PISSN: 1825859X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161-81.
2. Toh BH, Van Driel IR, Gleeson PA. Mechanisms of disease: Pernicious anemia. N Engl J Med 1997; 337:1441-8.
3. Martinelli T, Gleeson PA, Van Driel IR, Toh BH. Analysis of mononuclear cell infiltrate and cytokine production in murine autoimmune gastritis. Gastroenterology 1996; 110:1791-802.
4. De Block CE, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes:a clinically oriented review. J Clin Endocrinol Metab 2008; 93:363-71.
5. Centanni M, Marignani M, Gargano L, Corleto VD, Casini A, Delle Fave G, et al. Atrophic body gastritis in patients with autoimmune thyroid disease. Arch Intern Med 1999; 159:1726-30.
6. Segni M, Borrelli O, Pucarelli I, Delle Fave G, Pasquino AM, Annibale B. Early manifestations of gastric autoimmunity in patients with juvenile autoimmune thyroid distasse. J Clin Endocrinol Metab 2004; 89:4944-8.
7. Jacobson DL, Gange SJ, Rose NR, Graham NMH. Epidemiology and estimated population burden of selected autoimmune disease in the United States. Clin Immunol Immunopathol 1997; 84:223-43.
8. De Block CE, De Leeuw IH, Vertommen JJF, Rooman RPA, Du Caju MVL, Van Campenhout CM, et al. Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes. Clin Exp Immunol 2001; 126:236-41.
9. Betterle C, Dal Pra C, Mantero F, Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002; 23:327-64.
10. Weetman AP. Non-thyroid autoantibodies in autoimmune thyroid disease. Best Practice Res Clin Endocrinol Metab 2005; 19:17-32.
11. De Block CE, De Leeuw IH, Decochez K, Winnock F, Van Autreve J, Van Campenhout CM, et al. Belgian Diabetes Registry. The presence of thyrogastric antibodies in first degree relatives of type 1 diabetic patients is associated with age and proband antibody status. J Clin Endocrinol Metab 2001; 86:4358-63.
12. Elisei R, Mariotti S, Swillens S, Vassart G, Ludgate M. Studies with recombinant autoepitopes of thyroid peroxidase: evidence suggesting an epitope shared between the thyroid and the gastric parietal cell. Autoimmunity 1990; 8:65-70.
13. Baxter AG, Jordan MA, Silveira PA, Wilson WE, Van Driel IR. Genetic control of susceptibility to autoimmune gastritis. Int Rev Immunol 2005; 24:55-62.
14. Van Driel IR, Read S, Zwar T, Gleeson PA. Shaping the T cell repertoire to a bona fide autoantigen: lessons from autoimmune gastritis. Current Opin Immunol 2005; 17:570-6.
15. Ma JY, Borch K, Sjostrand SE, Janzon L, Mardh S. Positive correlation between H,K-Adenosine Triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol 1994; 29:961-5.
16. Annibale B, Aprile MR, D'ambra G, Caruana P, Bordi C, Delle Fave G. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 2000; 14:625-34.
17. Negrini R, Savio A, Poiesi C, Appelmelk B, Buffoli F, Paterlini A, et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996; 111:655-65.
18. Faller G, Winter M, Steininger H, Lehn N, Meining A, Bayerdorffer E, et al. Decrease of antigastric autoantibodies in Helicobacter pylori gastritis after cure of infection. Pathol Res Pract 1999; 195:243-6.
19. Oksanen A, Sipponen P, Karttunen R, Miettinen A, Veijola L, Sarna S, et al. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut 2000; 46:460-3.
20. Kohlstadt IC, Antunez De Mayolo EA. Parietal cell antibodies among Peruvian with gastric pathology changes. Scand J Gastroenterol 1993; 28:973-7.
21. De Block CE, De Leeuw IH, Bogers JJ, Pelckmans PA, Ieven M, Van Marck EA, et al. Helicobacter pylori, parietal cell antibodies and autoimmune gastropathy in type 1 diabetes mellitus. Aliment Pharmacol Therap 2002; 16:281-9.
22. Villako K, Kekki M, Maaroos HI, Sipponen P, Tammur R, Tamm A, et al. A 12-year follow-up study of chronic gastritis and Helicobacter pylori in a population-based random sample. Scand J Gastroenterol 1995; 30:964-7.
23. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996; 184:387-96.
24. Taguchi O, Takahashi T. Administration of anti-interleukin-2 receptor alfa antibody in vivo induces localized autoimmune disease. Eur J Immunol 1996; 26:1608-12.
25. Gleeson PA, Toh BH, Van Driel IR. Organ-specific autoimmunity induced by lymphopenia. Immunol Rev 1996; 149:97-125.
26. Alderuccio F, Toh BH, Tan SS, Gleeson PA, Van Driel IR. An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus. J Exp Med 1993; 178:419-26.
27. Alderuccio F, Gleeson PA, Berzins SP, Martin M, Van Driel IR, Toh BH. Expression of the gastric H/K-ATPase alfa subunit in the thymus may explain the dominant role of the beta-subunit in the pathogenesis of autoimmune gastritis. Autoimmunity 1997; 25:167-75.
28. D'Elios MM, Bergman MP, Azzurri A, Amedei A, Benagiano M, De Pont JJ, et al. H(+),K(+)-ATPase (Proton Pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 2001; 120:377-86.
29. Vergelli M, Hemmer B, Muraro PA, Tranquill L, Biddison WE, Sarin A, et al. Human autoreactive CD4 T cell clones use perforin or Fas/Fas ligand-mediated pathways for target cell lysis. J Immunol 1997; 158:2756-61.
30. Barrett SP, Van Driel IR, Tan SS, Alderuccio F, Toh BH, Gleeson PA. Expression of a gastric autoantigen in pancreatic islets results in non-distruttive insulitis after neonatal thymectomy. Eur J Immunol 1995; 25:2686-94.
31. Van Driel IR, Baxter AG, Laurie KL, Zwar TD, La Gruta NL, Judd LM, et al. Immunopathogenesis, loss of T cell tolerance and genetics of autoimmune gastritis. Autoimmun Rev 2002; 1:290-7.
32. Uibo R, Vorobjova T, Metskula K, Kisand K, Wadstrom T, Kivik T. Association of Helicobacter pylori and gastric autoimmunity: a population-based study. FEMS Immunol Med Microbiol 1995; 11:65-8.
33. Amedei A, Bergman MP, Appelmelk B, Azzurri A, Benagiano M, Tamburini C, et al. Molecular mimicry between Helicobacter pylori antigens and H+,K+-adenoide triphosphatase in human gastric autoimmunity. J Exp Med 2003; 198:1147-56.
34. D'Elios MM, Appelmelk BJ, Amedei A, Bergman MP, Del Prete GF. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med 2004; 10:316-23.
35. Ma JY, Borch K, Sjostrand SE, Janzon L, Mardh S. Positive correlation between H,K-Adenosine Triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. Scand J Gastroenterol 1994; 29:961-5.
36. Negrini R, Savio A, Poiesi C, Appelmelk B, Buffoli F, Paterlini A, et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996; 111:655-65.
37. Claeys D, Faller G, Appelmelk B, Negrini R, Kirchner T. The gastric H+/K+ ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998; 115:340-7.
38. Ohkusa T, Fujiki K, Takashimizu I, Kumagai J, Tanizawa T, Eishi Y, et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134:380-6.
39. Pettitt JM, Van Driel IR, Toh BH, Gleeson PA. From coiled tubules to a secretory canaliculus: a new model for membrane transformation and acid secretion by gastric parietal cells. Trends Cell Biol 1996; 6:49-53.
40. Callaghan JM, Khan MA, Alderuccio F, Van Driel IR, Gleeson PA, Toh BH. Alpha and beta subunits of the gastric H+/K(+)-ATPase are concordantly targeted by parietal cell autoantibodies associated with autoimmune gastritis. Autoimmunity 1993;16:289-95.
41. Gleeson PA, Toh BH. Molecular targets in pernicious anaemia. Immunol Today 1991; 12:233-8.
42. Burman P, Kampe O, Kraaz W, Loof L, Smolka A, Karlsson A, et al. A study of autoimmune gastritis in the postpartum period and at a 5-year follow-up. Gastroenterology 1992; 103:934-42.
43. Appelmelk B, Faller G, Claeys D, Kirchner T, Vanden-broucke-Grauls CM. Bugs on trial: the case of Helicobacter pylori and autoimmunity. Immunol Today 1998; 19:296-9.
44. Seetharam B, Alpers DH, Allen RH. Isolation and characterization of the ileal receptor for intrinsic factor-cobalamin. J Biol Chem 1981; 256:3785-90.
45. Toh BH, Alderuccio F. Pernicious anaemia. Autoimmunity 2004; 37:357-61.
46. Waters HM, Dawson DW, Howarth JE, Geary CG. High incidence of type II autoantibodies in pernicious anaemia. J Clin Pathol 1993; 46:45-7.
47. De Block CE, De Leeuw I, Bogers J, Pelckmans P, Ieven M, Van Marck E, et al. Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care 2003; 26:82-8.
48. Valnes K, Huitfeld HS, Brandtzaeg P. Relation between T cell number and epithelial HLA class II expression quantified by image analysis in normal and inflamed gastric mucosa. Gut 1990; 31:647-52.
49. Ye G, Barrera C, Fan X, Gourley WK, Crowe SE, Ernst PB, et al. Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells. J Clin Invest 1997; 99:1628-36.
50. Arnold R. Diagnosis and differential diagnosis of hypergastrinemia. Wien Klin Wochenschr 2007; 119:564-9.
51. Scarff KJ, Pettitt JM, Van Driel IR, Gleeson PA, Toh BH. Immunisation with gastric H+/K+-ATPase induces a reversible autoimmune gastritis. Immunology 1997; 92:91-8.
52. Murray CD, Kamm MA, Bloom SR, Emmanuel AV. Ghrelin for the gastroenterologist: history and potential. Gastroenterology 2003; 125:1492-502.
53. Correa P. Is gastric cancer preventable? Gut 2004; 53:1217-9.
54. Jevremovic D, Torbenson M, Murray JA, Burgart LJ, Abraham SC. Atrophic autoimmune pangastritis: a distinctive form of antral and fundic gastritis associated with systemic autoimmune disease. Am J Surg Pathol 2006; 30:1412-9.
55. Chlumskà A, Boudovà L, Benes Z, Zàmecnik M. Autoimmune gastritis. A clinicopathologic study of 25 cases. Cesk Patol 2005; 41:137-42.
56. Krasinskas AM, Abraham SC, Metz DC, Furth EE. Oxyntic mucosa pseudopolyps: a presentation of atrophic autoimmune gastritis. Am J Surg Pathol 2003; 27:236-41.
57. Granel B, Serratrice J, Disdier P, Laugier R, Weiller PJ. Asymptomatic gastric phytobezoar and anaemia due to iron deficiency revealing an autoimmune gastritis. Presse Med 2004; 33:1180-2.
58. Hsing AW, Hansson LE, McLaughlin JK, Nyren O, Blot WJ, Ekbom A, et al. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993; 71:745-50.
59. Sjöblom SM, Sipponen P, Järvinen H. Gastroscopic follow up of pernicious anaemia patients. Gut 1993; 34:28-32.
60. De Block CE, Colpin G, Thielemans K, Coopmans W, Bogers JJ, Pelckmans PA, et al. Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes. Diabetes Care 2004; 27:1387-93.
61. Borch K, Stridsberg M, Burman P, Rehfeld JF. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis. Scand J Gastroenterol 1997; 32:198-202.
62. Peracchi M, Gebbia C, Basilisco G, Quatrini M, Tarantino C, Vescarelli C, et al. Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids. Eur J Endocrinol 2005; 152:443-8.
63. Alonso N, Granada ML, Salinas I, Lucas AM, Reverter JL, Junca J, et al. Serum pepsinogen I an early marker of pernicious anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 2005; 90:5254-8.
64. Suzuki H, Masaoka T, Hosoda H, Nomura S, Ohara T, Kangawa K, et al. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio-A possible novel and non-invasive marker for gastric atrophy. Hepatogastroenterology 2004; 51:1249-54.
65. Checchi S, Montanaro A, Pasqui L, Ciuoli C, Cevenini G, Sestini F, et al. Serum ghrelin as a marker of atrophic body gastritis in patients with parietal cell antibodies. J Clin Endocrin Metab 2007; 92:4346-51.
66. Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood 2006; 107:1673-9.
67. Giovanella L, La Rosa S, Ceriani L, Uccella S, Erba P, Garancini S. Chromogranin-A as a serum marker for neuroendocrine tumors: comparison with neuron-specific enolase and correlation with immunohistochemical findings. Int J Biol Markers 1999; 14:160-6.
68. Mattar R, Alves de Andrade CR, DiFavero GM, Gama-Rodrigues JJ, Laudanna AA. Preoperative serum levels of CA 72-4, CEA, CA 19-9, and alpha-fetoprotein in patients with gastric cancer. Rev Hosp Clin Fac Med Sao Paulo 2002; 57:89-92.
69. Ychou M, Duffour J, Kramar A, Gourgou S, Grenier J. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Dis Markers 2000; 16:105-10.
70. Hawa M, Beyan H, Leslie RD. Principles of autoantibodies as disease-specific markers. Autoimmunity 2004; 37:253-6.
71. Tucci A, Bisceglia M, Rugge M, Tucci P, Marchegiani A, Papadopoli G, et al. Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointest Endosc 2007; 66:881-90.
72. Annibale B, Negrini R, Caruana P, Lahner E, Grossi C, Bordi C, et al. Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection. Helicobacter 2001; 6:225-33.
73. Presotto F, Sabini B, Cecchetto A, Plebani M, De Lazzari F, Pedini B, et al. Helicobacter pylori infection and gastric autoimmune diseases: is there a link? Helicobacter 2003; 8:578-84.
74. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Longterm course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996; 31:546-50.
75. Bright GM, Blizzard RM, Kaiser DL, Clarke WL. Organspecific autoantibodies in children with common endocrine diseases. J Pediatr 1982; 100: 8-14.